Offer - Urjas Oil for just ₹ 1 X
Revlamer 800 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Increased Phosphate Levels in the Blood. Secondary and off-label uses of Revlamer 800 Mg Tablet have also been mentioned below.
The right dosage of Revlamer 800 Mg Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Revlamer 800 Mg Tablet side effects, there are can be others also. These have been listed below. These side effects of Revlamer 800 Mg Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Revlamer 800 Mg Tablet's effect is Unknown during pregnancy and Safe for lactating mothers. Further, the section on Revlamer 800 Mg Tablet related warnings talks about Revlamer 800 Mg Tablet's effects on the liver, heart and kidney.
Revlamer 800 Mg Tablet is contraindicated in people with pre-existing medical conditions like Intestinal Obstruction as it can result in adverse effects. The section on Revlamer 800 Mg Tablet contraindications lists all such conditions.
Besides this, Revlamer 800 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Revlamer 800 Mg Tablet is considered safe while driving, and is addictive.
Revlamer 800 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Is the use of Revlamer 800 Mg Tablet safe for pregnant women?
No research has not been done till date on the safety of Revlamer for pregnant women. So its effects on pregnant women are unknown.
Is the use of Revlamer 800 Mg Tablet safe during breastfeeding?
Revlamer is completely safe for breastfeeding women.
What is the effect of Revlamer 800 Mg Tablet on the Kidneys?
Revlamer may have mild side effects on the kidneys.
What is the effect of Revlamer 800 Mg Tablet on the Liver?
Information about safety of Revlamer for the liver is not available since scientific research on this is yet to be done.
What is the effect of Revlamer 800 Mg Tablet on the Heart?
Information about safety of Revlamer for heart is not available since scientific research on this is yet to be done.
If you are suffering from any of the following diseases, you should not take Revlamer 800 Mg Tablet unless your doctor advises you to do so -
Is this Revlamer 800 Mg Tablet habit forming or addictive?
Forming a habit of Revlamer 800 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Revlamer 800 Mg Tablet as it does not make you drowsy.
Is it safe?
Yes, but consume Revlamer 800 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Revlamer 800 Mg Tablet in mental disorders is not effective.
Interaction between Food and Revlamer 800 Mg Tablet
Due to the absence of research, it is difficult to say how Revlamer 800 Mg Tablet and food will interact.
Interaction between Alcohol and Revlamer 800 Mg Tablet
Due to lack of research, there is no information about the side effects of taking Revlamer 800 Mg Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135